Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-05-04FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA granted supplemental approval for atorvastatin calcium from Dr. Reddy's Laboratories Limited under an ANDA.
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease [Phase 2]
Phase 2 clinical trial update assessing safety and tolerability of VK2809 in patients with primary hypercholesterolemia and non-alcoholic fa…
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling [Phase 4]
A Phase 4 trial exploring the relationship between insulin resistance and statin-induced type 2 diabetes with integrative omics profiling.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Acute Microvascular Changes With LDL Apheresis
A completed clinical trial investigating acute microvascular changes associated with LDL apheresis for hyperlipidemia; results posted in 202…
-
FDA approval · 2021-03-31FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc.,USA)
FDA approved a supplemental application for Colesevelam hydrochloride from Glenmark Pharmaceuticals Inc., USA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-03-17FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Dr.Reddys Laboratories Inc)
FDA approved a supplemental application for a generic ezetimibe and simvastatin product from Dr. Reddy's Laboratories, authorizing its marke…
-
FDA approval · 2021-03-15FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for pravastatin sodium to allow Aurobindo Pharma Limited to market a generic pravastatin product in …
-
FDA approval · 2021-03-09FDA Approved: CHOLESTYRAMINE — Original Application (Precision Dose, Inc.)
FDA approved an original ANDA for cholestyramine from Precision Dose, Inc., providing a generic version of the bile acid sequestrant.
-
FDA approval · 2021-03-08FDA Approved: GEMFIBROZIL — Supplemental Application (Northstar RxLLC)
The FDA approved a supplemental application for Gemfibrozil (generic; Northstar RxLLC) under an ANDA.
-
FDA approval · 2021-03-05FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare's generic pravastatin sodium, updating its regulatory status as an approved ge…
-
FDA approval · 2021-02-23FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for EZETIMIBE AND SIMVASTATIN by Ascend Laboratories, LLC. The approval covers changes under the…
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol [Phase 3]
Phase 3 clinical trial update evaluating atorvastatin in hyperlipidemic patients, focusing on LDL-cholesterol outcomes.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus [Phase 4]
Phase 4 trial update on atorvastatin and LDL profile in type 2 diabetes patients; study is terminated.
-
FDA approval · 2021-02-16FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for pravastatin sodium (generic pravastatin) under ANDA 076056.
-
FDA approval · 2021-02-11FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic Pravastatin Sodium product from Aurobindo Pharma Limited under an ANDA.
-
FDA approval · 2021-02-10FDA Approved: FENOFIBRATE — Original Application (Bostal LLC)
FDA approved the original application for fenofibrate by Bostal LLC, enabling the marketing of a generic fenofibrate product for lipid disor…
-
FDA approval · 2021-02-02FDA Approved: FENOFIBRATE — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for fenofibrate submitted by Solco Healthcare US, LLC.
-
FDA approval · 2021-02-01FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for pravastatin sodium (a generic statin). This represents an approved suppleme…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels [Phase 3]
Phase 3 trial evaluating an amlodipine/atorvastatin combination to reduce health risks from hypertension and hyperlipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia [Phase 4]
Phase 4 trial comparing co-administration of amlodipine/atorvastatin versus amlodipine alone in patients with hypertension and dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia. [Phase 4]
Open-label Phase 4 trial evaluating the effectiveness of an amlodipine-atorvastatin combination for hypertension and hyperlipidemia; complet…
-
FDA approval · 2021-01-15FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for atorvastatin calcium (generic atorvastatin) manufactured by Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia [Phase 4]
A Phase 4 trial comparing rosuvastatin/ezetimibe combination therapy to rosuvastatin alone in Korean patients with left ventricular diastoli…
-
FDA approval · 2021-01-13FDA Approved: GEMFIBROZIL — Original Application (XLCare Pharmaceuticals, Inc.)
FDA approved the original ANDA for Gemfibrozil from XLCare Pharmaceuticals, granting approval for a generic version of the lipid-lowering dr…
-
FDA approval · 2021-01-07FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for the fixed-dose combination of amlodipine besylate and atorvastatin calcium, manufactured by …